scispace - formally typeset
D

Do Young Kim

Researcher at Yonsei University

Publications -  737
Citations -  18320

Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation

TL;DR: In patients with HCC, survival after stopping sorafenib is poor, however, risk estimates based on a new “NEXT score” may help predict survival and prognosis even in patients who discontinue sorAFenib treatment.
Journal ArticleDOI

Self-textured transparent conductive oxide film improves efficiency of solar cells

Do Young Kim, +1 more
- 01 Jan 2010 - 
TL;DR: In this article, the authors proposed a self-texturing technique to increase the length of a photon's light path and enhance the absorption of light by reducing reflection on non-textured and textured surfaces.
Journal ArticleDOI

Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.

TL;DR: Based on the similar TACE treatment outcomes observed with the PSM analysis, the current T ACE treatment guideline for patients with TN-HCC might similarly be applied for patients for recurrent HCC after curative resection.
Journal ArticleDOI

Acquired bilateral nevoid telangiectasia: report of 9 cases

TL;DR: A superficial telangiectasia usually of the upper body, shows a unilateral dermatomal distribution, typically in the C3 to T3 dermatomes, which is speculated to be associated with hyperestrogenic states.
Journal ArticleDOI

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy.

TL;DR: Investigation in Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy with or without concurrent radiotherapy (CRT) revealed CS has a tendency to increase and the difference in CS between two groups decreased over time.